Eat Well Investment Group Inc. (EWG.CN)
| Previous Close | 0.1700 |
| Open | 0.0000 |
| Bid | 0.1800 x N/A |
| Ask | 0.1950 x N/A |
| Day's Range | 0.1700 - 0.1700 |
| 52 Week Range | 0.1600 - 0.2150 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | 26.651M |
| Beta (5Y Monthly) | -0.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
EAT WELL GROUP CLOSES $24.5 MILLION DEBT REFINANCING LED BY BUSINESS DEVELOPMENT BANK OF CANADA
Eat Well Investment Group Inc. (CSE: EWG) (US: EWGFF) (FSE: 6BC0) ("Eat Well" or the "Company"), a leading plant-based food agribusiness and CPG company, is pleased to announce that it has successfully closed its debt refinancing efforts with the Business Development Bank of Canada ("BDC") and a private lender (the "Private Lender"), as announced in its December 23, 2022 press release.
- CNW Group
EAT WELL GROUP TO SELL SAPIENTIA FOR USD $10 MILLION IN NASDAQ MERGER WITH MEDS & SUPERLATUS FOODS
Eat Well Investment Group Inc. (CSE: EWG) (US: EWGFF) (FSE: 6BC0), a leading plant-based food ingredient and CPG company, is pleased to announce it has entered into a definitive membership interest purchase agreement (the "MIPA") for its wholly-owned subsidiary, Sapientia Technology Inc., ("Sapientia") to Superlatus, Inc. ("Superlatus"), as part of a NASDAQ merger (the "Merger") with TRxADE HEALTH, Inc. (NASDAQ: MEDS).
- CNW Group
EAT WELL GROUP TO PRIORITIZE GLOBAL AG BUSINESS
Eat Well Investment Group Inc. (CSE: EWG) (US: EWGFF) (FSE: 6BC0) ("Eat Well" or the "Company"), a leading plant-based food ingredient and CPG company, is pleased to announce an enhanced focus on its global agribusiness initiative to drive debt reduction, improved profitability, and long-term success. The Company plans to achieve this through the following:
